Skip to main content

Find Clinical Trials

Home
Conditions
Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)

Clinical trial condition

Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)

Explore clinical trials studying Post-essential Thrombocythemia Myelofibrosis(Post-ET MF). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Post-essential Thrombocythemia Myelofibrosis(Post-ET MF) trial results

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis

NCT04217993

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details